vs

Side-by-side financial comparison of American Healthcare REIT, Inc. (AHR) and Qorvo, Inc. (QRVO). Click either name above to swap in a different company.

Qorvo, Inc. is the larger business by last-quarter revenue ($993.0M vs $564.0M, roughly 1.8× American Healthcare REIT, Inc.). Qorvo, Inc. runs the higher net margin — 16.5% vs 1.9%, a 14.6% gap on every dollar of revenue. On growth, American Healthcare REIT, Inc. posted the faster year-over-year revenue change (13.5% vs 8.4%). Over the past eight quarters, American Healthcare REIT, Inc.'s revenue compounded faster (11.7% CAGR vs 2.7%).

Medical Properties Trust, Inc. (MPT) is an international real estate investment trust (REIT) based in Birmingham, Alabama that purchases and invests in healthcare facilities and for-profit healthcare holding companies, primarily in the United States and Europe. Their property acquisitions often come in the form of sale-leaseback agreements, in which the original property owner sells the property to MPT and becomes their tenant. MPT's tenants are generally subject to long-term triple net lease...

Qorvo, Inc. is an American multinational company specializing in products for wireless, wired, and power markets. The company was created by the merger of TriQuint Semiconductor and RF Micro Devices, which was announced in 2014 and completed on January 1, 2015. It trades on Nasdaq under the ticker symbol QRVO. The headquarters for the company originally were in both Hillsboro, Oregon, and Greensboro, North Carolina, but in mid-2016 the company began referring to its North Carolina site as its...

AHR vs QRVO — Head-to-Head

Bigger by revenue
QRVO
QRVO
1.8× larger
QRVO
$993.0M
$564.0M
AHR
Growing faster (revenue YoY)
AHR
AHR
+5.2% gap
AHR
13.5%
8.4%
QRVO
Higher net margin
QRVO
QRVO
14.6% more per $
QRVO
16.5%
1.9%
AHR
Faster 2-yr revenue CAGR
AHR
AHR
Annualised
AHR
11.7%
2.7%
QRVO

Income Statement — Q4 FY2025 vs Q3 FY2026

Metric
AHR
AHR
QRVO
QRVO
Revenue
$564.0M
$993.0M
Net Profit
$10.8M
$164.1M
Gross Margin
14.8%
46.7%
Operating Margin
19.8%
19.4%
Net Margin
1.9%
16.5%
Revenue YoY
13.5%
8.4%
Net Profit YoY
133.9%
297.5%
EPS (diluted)
$0.07
$1.75

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AHR
AHR
QRVO
QRVO
Q4 25
$564.0M
$993.0M
Q3 25
$532.1M
$1.1B
Q2 25
$501.3M
$818.8M
Q1 25
$497.2M
$869.5M
Q4 24
$496.8M
$916.3M
Q3 24
$476.8M
$1.0B
Q2 24
$458.0M
$886.7M
Q1 24
$452.1M
$941.0M
Net Profit
AHR
AHR
QRVO
QRVO
Q4 25
$10.8M
$164.1M
Q3 25
$55.9M
$119.6M
Q2 25
$9.9M
$25.6M
Q1 25
$-6.8M
$31.4M
Q4 24
$-31.8M
$41.3M
Q3 24
$-4.1M
$-17.4M
Q2 24
$2.0M
$414.0K
Q1 24
$-3.9M
$2.7M
Gross Margin
AHR
AHR
QRVO
QRVO
Q4 25
14.8%
46.7%
Q3 25
14.6%
47.0%
Q2 25
15.0%
40.5%
Q1 25
13.0%
42.2%
Q4 24
13.3%
42.7%
Q3 24
12.5%
42.6%
Q2 24
12.1%
37.5%
Q1 24
10.7%
40.6%
Operating Margin
AHR
AHR
QRVO
QRVO
Q4 25
19.8%
19.4%
Q3 25
19.9%
14.9%
Q2 25
20.6%
3.7%
Q1 25
19.0%
3.2%
Q4 24
20.0%
5.8%
Q3 24
19.6%
0.9%
Q2 24
19.4%
0.5%
Q1 24
18.2%
3.2%
Net Margin
AHR
AHR
QRVO
QRVO
Q4 25
1.9%
16.5%
Q3 25
10.5%
11.3%
Q2 25
2.0%
3.1%
Q1 25
-1.4%
3.6%
Q4 24
-6.4%
4.5%
Q3 24
-0.9%
-1.7%
Q2 24
0.4%
0.0%
Q1 24
-0.9%
0.3%
EPS (diluted)
AHR
AHR
QRVO
QRVO
Q4 25
$0.07
$1.75
Q3 25
$0.33
$1.28
Q2 25
$0.06
$0.27
Q1 25
$-0.04
$0.33
Q4 24
$-0.23
$0.43
Q3 24
$-0.03
$-0.18
Q2 24
$0.01
$0.00
Q1 24
$-0.04
$0.04

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AHR
AHR
QRVO
QRVO
Cash + ST InvestmentsLiquidity on hand
$114.8M
$1.3B
Total DebtLower is stronger
$1.5B
Stockholders' EquityBook value
$3.3B
$3.7B
Total Assets
$5.4B
$6.2B
Debt / EquityLower = less leverage
0.42×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AHR
AHR
QRVO
QRVO
Q4 25
$114.8M
$1.3B
Q3 25
$147.4M
$1.1B
Q2 25
$133.5M
$1.2B
Q1 25
$86.1M
$1.0B
Q4 24
$76.7M
$769.4M
Q3 24
$67.8M
$1.1B
Q2 24
$52.1M
$1.1B
Q1 24
$77.0M
$1.0B
Total Debt
AHR
AHR
QRVO
QRVO
Q4 25
$1.5B
Q3 25
$1.5B
Q2 25
$1.5B
Q1 25
$1.5B
Q4 24
$1.5B
Q3 24
$1.5B
Q2 24
$1.5B
Q1 24
$1.5B
Stockholders' Equity
AHR
AHR
QRVO
QRVO
Q4 25
$3.3B
$3.7B
Q3 25
$2.7B
$3.5B
Q2 25
$2.4B
$3.4B
Q1 25
$2.3B
$3.4B
Q4 24
$2.3B
$3.4B
Q3 24
$2.2B
$3.4B
Q2 24
$1.9B
$3.5B
Q1 24
$2.0B
$3.6B
Total Assets
AHR
AHR
QRVO
QRVO
Q4 25
$5.4B
$6.2B
Q3 25
$4.8B
$6.1B
Q2 25
$4.5B
$6.0B
Q1 25
$4.5B
$5.9B
Q4 24
$4.5B
$6.0B
Q3 24
$4.7B
$6.5B
Q2 24
$4.6B
$6.4B
Q1 24
$4.7B
$6.6B
Debt / Equity
AHR
AHR
QRVO
QRVO
Q4 25
0.42×
Q3 25
0.44×
Q2 25
0.45×
Q1 25
0.46×
Q4 24
0.46×
Q3 24
0.45×
Q2 24
0.44×
Q1 24
0.44×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AHR
AHR
QRVO
QRVO
Operating Cash FlowLast quarter
$55.2M
$265.4M
Free Cash FlowOCF − Capex
$236.9M
FCF MarginFCF / Revenue
23.9%
Capex IntensityCapex / Revenue
2.9%
Cash ConversionOCF / Net Profit
5.12×
1.62×
TTM Free Cash FlowTrailing 4 quarters
$595.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AHR
AHR
QRVO
QRVO
Q4 25
$55.2M
$265.4M
Q3 25
$107.2M
$84.0M
Q2 25
$71.5M
$182.9M
Q1 25
$60.6M
$199.2M
Q4 24
$59.5M
$214.1M
Q3 24
$63.1M
$127.8M
Q2 24
$59.4M
$81.1M
Q1 24
$-6.0M
Free Cash Flow
AHR
AHR
QRVO
QRVO
Q4 25
$236.9M
Q3 25
$42.2M
Q2 25
$145.4M
Q1 25
$170.7M
Q4 24
$176.2M
Q3 24
$94.8M
Q2 24
$42.9M
Q1 24
FCF Margin
AHR
AHR
QRVO
QRVO
Q4 25
23.9%
Q3 25
4.0%
Q2 25
17.8%
Q1 25
19.6%
Q4 24
19.2%
Q3 24
9.1%
Q2 24
4.8%
Q1 24
Capex Intensity
AHR
AHR
QRVO
QRVO
Q4 25
2.9%
Q3 25
3.9%
Q2 25
4.6%
Q1 25
3.3%
Q4 24
4.1%
Q3 24
3.2%
Q2 24
4.3%
Q1 24
Cash Conversion
AHR
AHR
QRVO
QRVO
Q4 25
5.12×
1.62×
Q3 25
1.92×
0.70×
Q2 25
7.21×
7.15×
Q1 25
6.35×
Q4 24
5.19×
Q3 24
Q2 24
30.02×
195.86×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AHR
AHR

Integrated Senior Health Campuses$467.0M83%
SHOP$97.0M17%

QRVO
QRVO

ACG$690.8M70%
HPA$190.9M19%
CSG$111.3M11%

Related Comparisons